Location: Home
  • search
  • go
  • Relate News
  • 8/8/2025Wuxi Apptec Strengthens European Foothold with Luxembourg Expansion Am...
  • 8/8/2025Jingxin Gains Exclusive China Rights to Gedeon Richter's Schizophrenia...
  • 8/8/2025Recent Executive Moves
  • 8/8/2025Pharma MNCs in China H1/2025 – Mature Products Exit, Top Performers R...
  • 8/8/2025China Biopharma Tracker – July 2025: Funding Surges and Major Deals (...
  • 8/7/2025Innovation through Talent: How Leadership Is Evolving in China's Life ...
  • 8/6/2025Novartis Heart Drug A China Case Study: How Drug Exclusivity Dies by a...
  • 8/6/2025Big Pharma Provides Lifeline to Chinese Companies Struggling To Surviv...
  • 8/6/2025CDE Seeks Public Comments on Revised Technical Guidelines for Recombin...
  • 8/6/2025CDE Solicits Comments on Guidelines for Developing Appropriate Drug Pa...
  • 8/6/2025Fosun's Exit from Gland Pharma Stalls as Share Price Surge Complicates...
  • 8/6/2025Chinese Private Biopharma Sees Surge in July Financing, Highest Since ...
  • 8/6/2025MediLink and Akeso Launch First ADC–Ivonescimab Combo Trial
  • 8/6/2025China's CGT Boom: NMPA's CDE and Tsinghua Team Publish Eight-Year Revi...
  • 8/6/2025China Launches 11th National VBP Round with New Flexibility for Hospit...
  • 8/6/2025CDE Releases Updated Roster of External Drug Review Experts
  • 8/6/2025Global Pharma Bets on China's AI Biotech for Next-Gen Drug Discovery
  • 8/6/2025Everest's Nefecon Won NMPA Approval for Poduction Expansion to Meet Ri...
  • 8/6/2025XTalPi Signs US$6 Billion Global Drug Discovery Deal with DoveTree
  • 8/6/2025China Urges Price Discipline as Drugmakers Flood Latest VBP Tender
  • 8/5/2025Sanofi Withdraws Praluent from China Amid Strategic Shift
  • 8/5/2025China Issues 2025 Code of Ethics for Medical Professionals
  • 8/5/2025China Seeks Public Feedback on New Internet Drug and Device Informatio...
  • 8/5/2025Sciwind in Talks to License Weight-Loss Drug to U.S. Partner, Eyes Glo...
  • 8/5/2025TenNor Files for Hong Kong IPO to Fund Breakthrough Antibacterial Prog...
  • 8/5/2025China Biopharma Licensing Deals Soar in July, Driven by $500M Hengrui-...
  • 8/5/2025Sanofi Attributes Praluent's China Exit to Global Supply Strain and St...
  • 8/5/2025MediLink and Akeso Launch First Clinical Trial Combining Ivonescimab w...
  • 8/5/2025Innovent Secures FDA Clearance to Begin U.S. Trials for Oral GLP-1 Dru...
  • 8/5/2025China Approves AstraZeneca's Ultomiris for AQP4+ NMOSD
  • Page:4/786 Total number of articles:23552: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group